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Peptide-direeted antibodies were used to map the N-and C-termini of the turke), erythfoeyte//.:tdrenerl~ic receptor, tl~e full lenlJth recombinant 
r~eeptor expressed in Sf9 cells, anti a mutant hat terminates after residue 424 (T424), Both fomas ot" the natural receptor (P40 and P'~0) were 
p;oteolytteally clipped between residues 419 and 424. P40. but not PS0. is also proteolyzed between residues 14 and 28, Truncation mutants, Inat 
not full tcngth receptors, also display both large and small forms, The short form of T424 iS t'ormed by proteolysis after residue 14. but neither 
form is proteolyzed in the C-terminal region, The wild type recombinant receptor ixnot proleol~,,zed. 
/;.adrenergic receptor; Proteolysis; lmmunogenic peptide; Antibody 
i.  INTRODUCTION 
The /3.adrenergic receptor  is based on a bund le  o f  
seven membrane-spann ing  helices that form the l igand 
b ind ing  pocket  ([1.3] for reviews), A short ,  ex- 
t racel lu lar  N . te rmina l  domain  is apparent ly  not  re- 
<luired for receptor  funct ion,  but is N .g lycosy lated and 
is impor tant  for receptor  assembly.  The cytop lasmic  C- 
terminal  domain  varies in length among d i f ferent  recep- 
tors,  The /3-adrenergic receptor  f rom turkey 
erythrocytes has an unusual ly  long C- termina l  domain ,  
~s do  a few other  G prote in ,coup led  receptors.  T runca-  
t ion o f  this region causes the receptor  to be e×pressed at 
h igher  levels, to be  capab le  o f  agon is t - induced en- 
docytos is  and down-regu la t ion ,  andto  d isp lay several 
other  phenotyp ic  hanges [4,5]. It is unknown how the 
extreme C . termina l  region exerts these ef fects.  
The avian ~-adrenerg ic  receptor  pur i f ied f rom turkey 
erythrocytes d isp lays  twoe lect rophoret i c  components ,  
referred to as P40 and  P50 accord ing to their  apparent  
sizes on SDS-PAGE [6-10]. Both forms are active. P40 
is deglycosy lated and lacks an N- termina l  pept ide  
epitope,  which led Jurss  et al. [10] to  conc lude that  P40 
is fo rmed f rom PS0 by proteolys is  near the N . te rminus .  
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Because P40 retains Arc  ~'J [11,12], proteo lys is  must 
have  occurred betweetJ res idues 15 and  28. Yarden c ta l ,  
[12] found that P40 a lso lacks ext reme C , termina l  se. 
quences that are predicted from the eDNA sequence,  
but d id  no~ examine PS0. 
A l though recombinant /3 -adrenerg ic  receptor  appears  
as a single g lycoprote in  species when expressed in 
several  d i f ferent  cells [4,13]; the t runcated receptors  ap-  
pear  as two bands that are reminiscent o f  P40 and PS0 
[5]. The  smal ler form lacks N. l inked carbohydrate ,  as 
does  P40. Because o f  the newiy apprec ia ted  impor tance  
o f  the C- termina l  region and because C- termina l  trun.  
cat ion  promotes  the fo rmat ion  o f  two e lect rophorct ic  
,~pecies, we have now mapped the N-and  C- termina l  o f  
severa l  avian ~-adrenergic receptor  species. 
2. MATERIALS  AND METHODS 
Peptides (Fig. 1) were synthesized and coupled to hemocyanin or 
soy trypsin inhibitor [14], Mice wei~e immunized with the co1:jugate 
using standard protocols and, in some cases, were boosted in com. 
plete Freund's adjuvant to obtain ascites fluid [I 51. Antiserum against 
peptide Xlll was prepared in rabbits [9], 
3-Adrcnergic receptors were purified from turkey erythrocytes [16] 
or from Sf9 cells infected with recombinant baculovirus [13], Two 
truncation mutants. T424 and T397. were constructed by replacing 
c0dons 398 and 425 iv. the wild type eDNA with termination ¢odons 
[5]. Receptors were photo;affinity labeled with ['2~l]iodocyanopin. 
dolol.diazirine I17] (Amersham) as described [11]. Samples for elec. 
trophoresis were reduced and alkylated [11] and electrophoresed on 
8070 polyacrylamide g ls [18]. Gels were soaked for 10 rain in 25 mM 
Tris-195 mM glyeine (pH 8.3) and transferred to nitrocellulose in the 
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Fil3; I ,  Loeadon tn the avian IJ.atlrenergic receptor of peptides used 
for immunization (see [12] for the complete sequenc¢~). Peptide v 
(2~0-265), CGSQEQPPPLQI'|QP; peptide Xi (470-483), CHKLKH.  
KWRFKQHQA; peptide XII (416-429), CKTSRSESKMEREKN: 
peptide XI)a (~16-424), KTSRSESKM {the first S amino acids of pep- 
tide XII); peptide X l l l  (2;-10), GDGWLPPDC. 
same buffer (50 V; [ h; 4*C). Blots were probed according to Harris 
et ah [19} or, for anti-Xlll serum. Dunkel et al. [9}. None of the ira. 
mtmoreactive bands referred to in the text were observed if the 
primary antibodies were exposcd firsl to the immunogenic peptide. 
There was no effect of control peptides. Peptide blockade ex- 
periments are not sl~own except in Fig. 4. A small band below the P40 
form of the receptor purified-from erythrocytes i  specifically im- 
mtmoreactivc. Photoaffinity labelil~g indicates that it is a proteolytic 
product of the receptor (not showlt), 
3. RESULTS AND DISCUSSION 
The electrophoretic mobiHties o f  photoaff in i ty label- 
ed /.3-adrenergic receptors are shown in Fig. 2, Recep. 
tots purified f rom turkey erythrocytes displayed two 
bands, PS0 and 1:'40, as described previously [8-10]. 
The  full length recombinant receptard isp layed an ap- 
parent Mr o f  45 kDa, slightly smaller than the P50 form 
of  the natural receptor. The Mr o f  the full length recep- 
tor predicted f rom its eDNA sequence is 54078, znd it 
should behave as an even larger species because o f  
glycosylation. Its electrophoretic mobil ity is thus 
anomalously high. Mutants truncated after residues 424 
or 397 both displayed two electrophoretic species (see 
also [5]). In the case o f  T424, one band migrated at 
about 43 kDa and the other at about 37 kDa. Similar 
results were obtained when these receptors were ex- 
pressed in Sf9 [13]) L [4] and COS [5] cells. 
Because the two forms of  the natural receptor andof  
the truncation mutants might differ as a result of pro- 
teolysisi g lycosylat ion or other modif icat ion, we raised 
antibodies against selected amino acid sequences in the 
receptor (Fig. 1) to determine whether specific N- and 
C-terminal regions had been removed (Fig. 3). The wild 
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Fif~. 2. SDS pol~tcryhtmide gel ¢lcctrophoresis of ICYP~dia~irin~ 
labeled recept~rs, WT, full lenl/Jh recombinant receptor; T424 and 
T397, rec0mblnan! reccptor~ truncated at'ter esidues 424 anti 397: 
RBC, reeeotor purified front turkey erycllrocytes (2 difl'eren~ prepar.- 
t|ot~s). All b~tnds were blocked by inclusion t~f propranolol {tt the 
labelin~ mixture (not shown); 
type recombinant  receptor expressed in Sf9 cells was 
not proteolyzed, It retained N-terminal epitopes 
detected by ant i -X I l I  serum ( lane 14), N.l inked 
glycosylat ion at Asn t" [131 and C-terminal epitopes 
detected by ant i -XI  serum (lane 5), Epitopes in the third 
cytoplasmic loop and in the middle o f  the cytoplasmic 
C-terminal  domain  were als0 detected by anti-V serum 
and either o f  two ant i -X l l  sere, respectively (lanes 
2,8,11). Reactivity with anti-V serum, which detects in- 
ternal epitopes, is used for quant i tat ive compar ison 
among different receptors o r  between two forms era  
single receptor. 
Only  the larger form of  T424 reacted with ant i -Xl l l  
seru m (lane t 3), indicating that the smaller form is pro-  
teolyzed at its N-terminus, which is consistent with its 
smaller size and its loss o f  glycosylation at Asn 14 [5]. 
Both forms o f  T424 reacted with either o f  two anti -XI l  
sere (lanes 7 and 10), which shows that neither form is 
proteolyzed significantly, i f  at  all, at the C-terminus. 
Genetic t runcat ion o f  the C-terr.~inus thus predisposes 
the receptor to N-terminal proteolysis. As  a control ,  we 
68 - -  - -  - -  68 
Fig. 3. Immunoblots of either purified T424 (4.5 pmot)', membranes 
of Sf9 cells that contain full length recombinant receptor (WT; 120 
fmol. 30 ~g protein); cr receptor purtfied from turkey ery0~rocytes 
(RBC; 22 proP!). The different anti..peptide antisera were di' uted so 
that the Full length receptor yielded a clear signal usin ~ anti.V serum, 
thus allowing comparison with the signals obtained with the other 
sere. None of the bands was observed if the serum was preincubated 
wit]~ the immunogenic pep/|de xcept he 68 kDa band. which is also 
found in cells infected with wild type virus and, occasionally, in 
uninfected cells. 
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which lies beyond the trune~i~n, wnd thus did ~QI IWCE 
with anti-XI Serum. --a3 
A sJmilPrr set of cxpcrimcnrr ~~ggestr that bnrrh fhc 
P48 and PSO fermr of fhe natural i%xlrcncrgic rreeptcrr 
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arc prarenlyaed bcfoi% rcridui! 424, the region cantuin- 
ed in irnmlmoyrnie ycpride Xlt. First, neither 840 nor 
P.50 rat&d with 61nri-Xl sxum tlanc a), indicating that 
th$ extreme Caxminnl region Ir missing from both Fiy. 4. Welrllr al pPrii\r\lb~\ioa tirtin\i+SII \,cII Wilh ilWW pc@rlrr Sll 
forms. 840 and PI0 also did not react with serum Xll.4 nr u fril@fTtcilf, prpcictr Sllri., t,crr ~tinci. Puritlrtf T@4: 3 pinul; w1” 
(lane 12). They did react with serum X11.1, but only 
mcnrtwatw, ISO fmul, W1’ iw sucrlaatlcd Im susnipcrhn, wl~izlr 
nrqtle 1~~~4dadtctl htnda twrc ubvlcnrrt. itight grupA. HC~S~WP 
weakly campered with T424, which ‘ruggcrra f hat f he C- purilietl lrum R&C, I4 pfnnl; pari&rl fJ?dl, 1 pmol. Control rr’plitlc 
tcrrnini of P40 and P50 lie before residue 424. Pcptidc V W\I, WY.l 1\1 raa ,r@m\ alIt\ peptitlcx XII mrtl Xltrr WCPZ wetl 8\ IO 
bloekadc experiments (Fig, 4) support this iclett. Ssrum &xIl. 
X11,1, which reacted with borh P40 and P50, detects 
only determinants before residue 424 because its rcac- 
tivity Gth wild type receptor ws complerely blocked by rruncoted rcccptars pass. We do not know wherkcr the 
either peptide XII (residues 416-429) or by a fragment C-terminal protcalysi~ of eeucpfora ilr erythroeyrcr is 
of pcpridc XII, pepride XIIa (residues 416424). Serum responsible for rhe further proteolysis of P50 to P40, 
XIEA, which did not react with P40 or PSO, detects Expcrimcnrs fo determine rhc flux of mutant and wild 
epitopen predominantly in the: Germinal part of pep- type receptors through the cell arc in progress, 
tide XII. Its. reaction with wild rypc rceepror WDS in- 
hibited only incomplerely by pepride XlIa but was cont- ~l~~‘~f~~~clrr/~,e/,rrrr(b: This work was srrpporrcd by NtH Grenr 
plcfcly blocked by peptidc XII, From the~cdata we con- GM20356 and R.A. \Velrh Faundstian Grant 1982. Wark carried QII~ 
cIude that the site of C-terminal proteolysis of P40 and by hl,H. in IhC laborntcary of &at’. E.J.M. Hclmreich (Wiifrburg) 
P50 lies within the span of pcptidc XIIa, after rcsiduc 
wils rupparlctl by grants I’ram fllc Dculwhc Porsckun~~~clnci~isc~~~~fl 
4 16 but before residue 424, As reported by Dunkcl et al, 
tls22/1Q.I and Prrrjcet Grant Al IO E.J.M.H. of Suncfcr. 
rarscliungsbcrcisll I76 aad by Ihe FontIs dcr Chcmischcn Ind~srrie 
[9], P40 is N-terminally protcolyzed. It lacks both car- c,V. M.H. wishes IQ ask~rawlrdgr IIW intrresr and support of Pral’. 
bohydrate [8,10] and N-terminal cpitopc XIII ([9] and Ernst .I.hl. Hclmrcich. WC thank Dr. Eric M. Parlwr’ l’or voluablc 
lane 15). discussion. 
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